Navigation Links
Type 1 Diabetes May Develop More Slowly Than Thought
Date:2/21/2012

TUESDAY, Feb. 21 (HealthDay News) -- Insulin production may continue for decades after the onset of type 1 diabetes, according to a new study.

The findings add to growing evidence that the period of time for treatment after the onset of the disease is longer than previously believed, the Massachusetts General Hospital researchers said.

"Traditionally, it was thought that beta cell function completely ceased in patients with advanced type 1 diabetes. However, data from this study and others suggest that the pancreas continues to function at some level even decades after the onset of type 1 diabetes," study leader Dr. Denise Faustman, director of the MGH Immunobiology Laboratory, said in a hospital news release.

Beta cells are a type of cell in the pancreas that produce and store insulin.

The researchers analyzed blood samples from 182 patients with type 1 diabetes and found that C-peptide production can continue for decades after disease onset and remains responsive to blood sugar levels. C-peptide is a marker of insulin secretion/beta cell function.

C-peptide levels were lower in patients who had type 1 diabetes for a longer time, but the decrease was gradual and not the sudden decline believed to occur in people with the disease.

Even among patients who'd had type 1 diabetes for 31 to 40 years, 10 percent still produced C-peptide and beta cell functioning remained intact at very low C-peptide levels, according to the study in the March issue of the journal Diabetes Care.

Researchers say the new findings suggest that type 1 diabetes patients with low C-peptide levels or advanced disease may benefit from new treatments to preserve or enhance beta cell function.

"Our results contribute to a growing body of evidence suggesting there might be a longer window for therapeutic intervention in this disease and also may help explain the transient restoration of insulin production we saw in patients who received BCG (the generic drug bacillus Calmette-Guerin) in our phase 1 clinical trial," Faustman said.

More information

Juvenile Diabetes Research Foundation International has more about type 1 diabetes.

-- Robert Preidt

SOURCE: Massachusetts General Hospital, news release, Feb. 21, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. As diabetes emerges, researchers track diseases first steps
2. Diabetes may start in the intestines, research suggests
3. When Mom Has Pregnancy Diabetes, Breast-Feeding Curbs Child Obesity
4. 4 New Genes Linked to Type 2 Diabetes
5. Metformin Preferred Drug for Type 2 Diabetes, Experts Say
6. Pancreas May Taste Fructose, Hinting at Links to Diabetes
7. Donation opens new opportunities for more effective diabetes treatment
8. Diabetes Takes Toll on Womens Hearing: Study
9. Diabetes rates vary widely in developing countries, 1 in 10 cases untreated
10. Type 1 Diabetes Treatment Disappoints in Trial
11. Popular Diabetes Drug Might Cut Pancreatic Cancer Risk: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Type 1 Diabetes May Develop More Slowly Than Thought
(Date:3/28/2017)... ... March 28, 2017 , ... ... and services, is proud to announce it has joined the National Association for ... the interests of chronically ill, disabled, and dying Americans of all ages and ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, ... the launch of a free, public-facing tool for analyzing the costs of various ... to provide comparative information to patients, providers, insurers and pharmaceutical companies about the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, a ... Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip ... in association with efforts by the American College of Surgeons, U.S. Department of ...
(Date:3/28/2017)... ... 28, 2017 , ... Usually, the impending arrival of warmer weather means the ... about a double chin, this means more anxiety than elation. The cosmetic dermatology experts ... people, a double chin is undesirable,” Dr. Goldman said, “but it seems doubly so ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, ... ensuring high-quality results and maintaining GMP and USP compliance. In a new webinar ... with GMP requirements " these requirements are explained. The challenge is to ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)...  Las Vegas ophthalmology practice, Center For Sight, announced ... Dublin ), an implant that shunts ... intraocular pressure in patients with moderate to severe glaucoma. ... glaucoma that can lead to progressive optic nerve damage ... untreated. According to the National Eye Institute, ...
(Date:3/28/2017)... 2017 The U.S. Food and Drug ... adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is ... adequately by topical therapies, or those for whom ... used with or without topical corticosteroids. ... approving new and innovative therapies for patients with ...
(Date:3/28/2017)... , March 28, 2017  "US Cancer Generics ... the various indicators and trend analysis related to ... in mainstream pharmaceutical market in US. The report ... the growth on cancer generics drugs in recent ... saving of billions of dollars for various stake ...
Breaking Medicine Technology: